Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionReader Login
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 211 Print this page  Email this page Small font size Default font size Increase font size
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2011| July-September  | Volume 26 | Issue 3  
    Online since November 28, 2012

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience
Nishikant Damle, Manish Patnecha, Praveen Kumar, Sagar Maharjan, Chandrasekhar Bal
July-September 2011, 26(3):144-148
DOI:10.4103/0972-3919.103997  PMID:23326066
Background: Dedifferentiation of thyroid follicular cells renders radioiodine therapy ineffective in patients of differentiated thyroid cancer (DTC). An alternative therapy to treat the disease or reinduce radioiodine uptake is necessary. Materials and Methods: We evaluated the role of retinoic acid therapy in 13 cases of DTC with raised thyroglobulin and/or clinically evident disease. Retinoic acid was given in a dose of 1.5 mg/kg for a period ranging between 1.5 and 18 months. Results: Age of the patients was between 18 and 65 years with a median of 49 years. Ten patients had papillary while two had follicular and one patient had mixed papillary and follicular thyroid cancer. Mean radioiodine given before starting retinoic acid was 164 mCi. Mean duration of therapy was 6.4 months. Thyroglobulin decreased in 2 patients and increased in 11 patients at the end of therapy. Radioiodine uptake was demonstrable in six patients, though faintly, while 7 cases showed no uptake. Based on the clinical and biochemical parameters, four patients had progressive disease, eight had stable disease and one patient showed partial response. Of the six patients with reinduction of radioiodine uptake, three had biochemical progression and the other three had stable disease. Conclusion: Our findings suggest that retinoic acid therapy may induce radioiodine uptake and reduce serum thyroglobulin levels in some patients with DTC, but whether this results in clinically significant response can only be ascertained on long-term follow-up.
  2 1,768 139
CASE REPORTS
Spontaneously ruptured choledochal cyst: Rare diagnosis on hepatic scintigraphy
Suneel Chauhan, AG Pandit, MJ Jacob, Puneet Kumar
July-September 2011, 26(3):157-158
DOI:10.4103/0972-3919.104001  PMID:23326070
A 47-day-old female infant presented with congenital inguinal hernia, seizure on the 2 nd day of life, fever, progressive jaundice, acholic stools and distension of abdomen. She was suspected to have choledochal cyst with extrahepatic biliary atresia (EHBA) and referred for an Hepatobiliary Tc-99m iminodiacetic acid (HIDA) scan. On HIDA scan, a functional diagnosis of ruptured choledochal cyst was made which was not possible on anatomical imaging like ultrasound (USG)/computed tomography (CT) scan. This was supported thereafter by bilious aspirate on abdominal paracentesis. Immediate laparotomy with T-tube insertion was done. The child improved dramatically after the procedure. Biliary peritonitis secondary to cyst perforation or rupture is a rare complication reported to occur in 1-2% cases of choledochal cyst. Early diagnosis and management is the key to reduce the morbidity and mortality.
  1 1,329 71
Comparison of Tc-99m MDP and Sm-153 EDTMP bone scan
Krishnakumar Ramachandran, Kathiresan , Balkis Begum, Rangarajan
July-September 2011, 26(3):163-164
DOI:10.4103/0972-3919.104005  PMID:23326073
A 72-year-old male, a known case of carcinoma of prostate, had bilateral orchidectomy in 2002 and while on hormones developed multiple bone metastases in 2010. He was treated with 153 Samarium ethylene diamine tetra methylene phosphonate (EDTMP). The author compares the features of 99m Tc methylene diphosphonate (MDP) scan and 153 Sm EDTMP bone scan, highlighting the similarities of skeletal uptake.
  1 1,304 79
ORIGINAL ARTICLES
Lutetium DOTATATE whole body scans: A novel approach for evaluation of neuroendocrine tumors
Natasha Singh, BA Krishna, Madhusudan Vyas, Meera Venkatesh, Sharmila Banerjee, Tapas Das, KV Vimal Nair, Sudipta
July-September 2011, 26(3):135-138
DOI:10.4103/0972-3919.103994  PMID:23326064
Aim: We undertook a study to evaluate whether Lutetium (Lu) DOTATATE whole body scan is well comparable to Gallium positron emission tomography (PET) / Indium Octreotide, and hence with dosimetric advantage can replace it in the pre-therapy setting. Materials and Methods: We undertook a prospective study of a total of 39 patients with metastatic neuroendocrine tumor (age 11-70 years), who underwent Lu-DOTATATE scans within the period August 2009-November 2010. This included 28 males and 11 females. Dose of Lu-DOTATATE injected for diagnostic scanning purpose was 10 mCi i.v. Whole body planar images and single-photon emission computed tomography (SPECT)-CT images were obtained at 4, 24 and 48 hours. The Lu-DOTATATE whole body and SPECT-CT images were compared to contrast CT scans in all patients, and Indium Octreotide and Gallium DOTATATE PET images in nine patients, with reference to detection sensitivity of number of lesions. The pre-therapy scans were also used for dosimetric calculations. Fourteen of these 39 patients further went ahead with Lu-DOTATATE therapy. Results: All 39 patients demonstrated Lu-DOTATATE uptake in the disease sites seen on the contrast CT images. The uptake intensity was well comparable to Indium Octreotide and Gallium DOTATATE PET scans of all nine patients, with equally well-defined lesions. The post-therapy Lu-DOTATATE scans of the 14 patients who underwent therapy demonstrated higher intensity uptake pattern in the same disease sites, suggesting favorable therapeutic effect. The scans were useful in determining dosimetric details for therapeutic purpose and adequate exposure rates to suggest good ablative effect. Conclusion: Our preliminary data suggest that Lu-DOTATATE whole body scanning procedure is cost effective and equally sensitive as Gallium DOTATOC/NOC PET scan in pre-therapy setting of neuroendocrine tumors. The additional advantage of dosimetry calculations on this scanning procedure makes it more ideal to tailor therapies with more accuracy.
  1 6,457 283
CASE REPORTS
False-positive "halo" sign on testicular scintigraphy in a 5-year-old boy with epididymitis and hydrocele
Sampath Santhosh, Poonam Guha, Anish Bhattacharya, Monika Bawa, Bhagwant Rai Mittal
July-September 2011, 26(3):159-160
DOI:10.4103/0972-3919.104002  PMID:23326071
Scintigraphic differentiation between acute torsion, hydrocele and testicular or scrotal abscess can be difficult. Doppler sonography may provide useful complimentary information toward diagnosis. The authors describe a 5-year-old child where epididymitis with hydrocele was misdiagnosed as testicular torsion on scrotal scintigraphy.
  - 1,301 73
Tc99m-MDP uptake in ascitic fluid in a patient with prostate carcinoma: A clue to detect metastases
Dhritiman Chakraborty, Kuruva Manohar, Koramadai Karuppuswamy Kamleshwaran, Anish Bhattacharya, Baljinder Singh, Bhagwant Rai Mittal
July-September 2011, 26(3):161-162
DOI:10.4103/0972-3919.104003  PMID:23326072
Bone scintigraphy with Tc-99m methylene diphosphonate (MDP) is used to detect metastases in patients with cancer. Uptake in non-osseous, non-urologic tissues is occasionally found in the routine bone scintigraphy, which may mimic as metastatic lesions. The authors describe the case of a 70-year-old man with prostate cancer, showing diffuse tracer uptake in the left hemithorax and entire abdomen on bone scan that required additional imaging modality for localization. Careful interpretation is needed of the unusual uptake of radiotracer in regions other than the skeleton for metastatic work up.
  - 1,381 64
Autonomously functioning nodule arising from accessory mediastinal thyroid tissue
Karuppiah Kumaresan, N Sudhakar Rao, A Ram Mohan, M Sudhakar Rao
July-September 2011, 26(3):153-154
DOI:10.4103/0972-3919.103999  PMID:23326068
Functional imaging using radionuclide Tc99m pertechnetate is routinely used in the evaluation of the problems related to the thyroid gland. Scintiscan has been useful in the visualization of thyroid tissue in ectopic sites due to congenital developmental anomalies. Similarly, the scan helps in establishing the diagnosis of autonomously functioning nodule when the nodule being evaluated appears "hot" with suppression of rest of the gland activity. Here, we present a very rare case of autonomously functioning thyroid adenoma in an ectopic focus of accessory thyroid tissue in the mediastinum.
  - 906 88
Symmetric increased skeletal muscular uptake of F-18 fluoro-deoxyglucose: A clue for the diagnosis of Graves' disease
Sampath Santhosh, Bhagwant Rai Mittal, Raghava Kashyap, Anish Bhattacharya, Baljinder Singh
July-September 2011, 26(3):155-156
DOI:10.4103/0972-3919.104000  PMID:23326069
F-18 fluoro-deoxyglucose (FDG) uptake in the thyroid and thymus is well reported in patients with Graves' disease. Incidental skeletal muscle uptake has also been reported in other non-musculoskeletal (benign and malignant) pathologies. We report a patient of Graves' disease showing symmetrical skeletal muscle uptake but no thyroidal or thymus uptake of FDG.
  - 1,185 89
ORIGINAL ARTICLES
Comparative study of 18 F-DOPA, 13 N-Ammonia and F18-FDG PET/CT in primary brain tumors
Mattakarottu J Jacob, Aniruddha G Pandit, Charu Jora, Ravina Mudalsha, Amit Sharma, Harish C Pathak
July-September 2011, 26(3):139-143
DOI:10.4103/0972-3919.103996  PMID:23326065
Aim: To determine the diagnostic reliability of 18 F-FDOPA, 13 N-Ammonia and F18-FDG PET/CT in primary brain tumors. We evaluated the amino acid and glucose metabolism of brain tumors by using PET with 18 F-FDOPA, 13 N-Ammonia and F18-FDG PET/CT. Materials and Methods : Nine patients undergoing evaluation for brain tumors were studied. Tracer uptake was quantified by the use of standardized uptake values and the ratio of tumor uptake to normal identical area of contra lateral hemisphere (T/N). In addition, PET uptake with 18 F-FDOPA was quantified by use of ratio of tumor uptake to striatum uptake (T/S). The results were correlated with the patient's clinical profile. Results : Both high-grade and low-grade tumors were well visualized with 18 F-FDOPA. The sensitivity for identifying tumors was substantially higher with 18 F-FDOPA PET than with F18-FDG and 13 N-Ammonia PET as determined by simple visual inspection. The sensitivity for identifying recurrence in low grade gliomas is higher with 13 N-Ammonia than with F18-FDG. Conclusion: 18 F-FDOPA PET is more reliable than F18-FDG and 13 N-Ammonia PET for evaluating brain tumors.
  - 1,517 123
Gel clot bacterial endotoxin test of FDG: Indian scenario
Sarika Sharma, Bhagwant Rai Mittal, Rakhee Vatsa, Baljinder Singh
July-September 2011, 26(3):149-152
DOI:10.4103/0972-3919.103998  PMID:23326067
Background: The bacterial endotoxin test (BET) performed using gel clot method is a 60-min test and typically performed after the decay of the 2-( 18 F) fluoro-2-deoxy-d-glucose (F18-FDG) sample to determine the endotoxin content. The objective of this study protocol was to perform BET testing of F18-FDG by gel clot method. Materials and Methods: Ten random decayed samples of the F18-FDG were subjected to the gel clot BET. The assay was performed with undiluted F18-FDG and at four different maximum valid dilutions of 1:10, 1:100, 1:350 and 1:700 (total number of tests = 100). The sensitivity of the LAL reagent used was 0.125 EU/ml. Endotoxin dilutions were freshly prepared from control standard endotoxin (CSE) stock solution for each F18-FDG batch testing. If the gel had formed and remained intact in the bottom of the reaction tube after an inversion of 180°, the test was considered positive. Any other state of the reaction mixture constituted a negative test. Results: In the undiluted samples, the measured pH (7.05) was well within the acceptable range (i.e. 6.0-8.0) for the gel clot assay. Of the 10 undiluted F18-FDG batches and all the diluted samples, none gelled after 60-min incubation period at 37°C. However, the undiluted F18-FDG did inhibit gel formation at the lysate sensitivity of 0.125 EU/ml. Conclusion: The total volume of FDG produced was 16 ml in the synthesis module. The total F18-FDG preparation at any time did not contain more than 8 EU (0.5 EU/ml Χ 16 ml). Thus, the product is safe for human administration.
  - 1,927 117
Fourier phase analysis on equilibrium gated radionuclide ventriculography: Range of phase spread and cut-off limits in normal individuals
Vijayaraghavan L Ramaiah, B Harish, HV Sunil, Job Selvakumar, AG Ravi Kishore, Gopinathan Nair
July-September 2011, 26(3):131-134
PMID:23326063
Aim: To define the range of phase spread on equilibrium gated radionuclide ventriculography (ERNV) in normal individuals and derive the cut-off limit for the parameters to detect cardiac dyssynchrony. Materials and Methods: ERNV was carried out in 30 individuals (age 53±23 years, 25 males and 5 females) who had no history of cardiovascular disease. They all had normal left ventricular ejection fraction (LVEF 55-70%) as determined by echocardiography, were in sinus rhythm, with normal QRS duration (≤120 msec) and normal coronary angiography. First harmonic phase analysis was performed on scintigraphic data acquired in best septal view. Left and right ventricular standard deviation (LVSD and RVSD, respectively) and interventricular mechanical delay (IVMD), the absolute difference of mean phase angles of right and left ventricle, were computed and expressed in milliseconds. Mean + 3 standard deviation (SD) was used to derive the cut-off limits. Results: Average LVEF and duration of cardiac cycle in the study group were 62.5%±5.44% and 868.9±114.5 msec, respectively. The observations of LVSD, RVSD and right and left ventricular mean phase angles were shown to be normally distributed by Shapiro-Wilk test. Cut-off limits for LVSD, RVSD and IVMD were calculated to be 80 msec, 85 msec and 75 msec, respectively. Conclusion: Fourier phase analysis on ERNV is an effective tool for the evaluation of synchronicity of cardiac contraction. The cut-off limits of parameters of dyssynchrony can be used to separate heart failure patients with cardiac dyssynchrony from those without. ERNV can be used to select patients for cardiac resynchronization therapy.
  - 1,263 108
  Feedback